Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other Ethiologies

Extracorporeal Membrane Oxygenation in COVID-19, Influenza and ARDS of Other Ethiologies

A comparison of clinical characteristics and outcomes of patients on extracorporeal membrane oxygenation (ECMO) in COVID-19, influenza and ARDS of other ethiologies

All ARDS patients on extracorporeal membrane oxygenation (ECMO) during January 1st 2016 and January 10th 2022 in University Medical Center Ljubljana were included and their clinical characteristics and outcomes were studied according to ARDS ethiology: COVID-19, influenza and other ethiologies.

Inclusion Criteria:

• Patient with acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO)
• 18 years or older

Exclusion Criteria:

• Patient not eligible for ECMO treatment per institutional guidelines (terminal illness, palliative care)